Pharmaceutical Services

AHP Announces Formation of Prolerity Clinical Research and Investment in Tandem Clinical Research

AHP announces its investment in Prolerity Clinical Research (“Prolerity”), a clinical research site management network. As a cornerstone to the formation of Prolerity, AHP has made a majority investment in Tandem Clinical Research, LLC (“Tandem”), which operates 11 research sites across Louisiana, Florida, New Jersey, and New York. Prolerity is focused on expanding into a

AHP Announces Formation of Prolerity Clinical Research and Investment in Tandem Clinical Research Read More »

Q4 2023 Update: Private Equity Deals in the Pharmaceutical Industry in the US

In the US pharmaceutical industry, there were 31 private equity deals announced in Q4 2023, worth a total value of $700.5m, according to GlobalData’s Deals Database. The $375m management buy-in (mbi) ZimVie by H.I.G. Capital was the industry’s largest disclosed deal. In value terms, private equity deal activity in the US decreased by 84% in

Q4 2023 Update: Private Equity Deals in the Pharmaceutical Industry in the US Read More »

Petauri™ Acquires FORCE Communications

Petauri, a purpose-built pharmaceutical services platform, announced its acquisition of FORCE Communications and its 3 independent companies, DRIVE, MOMENTUM, and PROPEL, which bring science to life on behalf of clients and their medical innovations. Founded in 2001 by Jay Greenzweig, RPh, FORCE Communications provides pharmaceutical, biotech, and medical device clients with customized medical communication and

Petauri™ Acquires FORCE Communications Read More »

Petauri™ Acquires FORCE Communications

Petauri, a purpose-built pharmaceutical services platform, announced its acquisition of FORCE Communications and its 3 independent companies, DRIVE, MOMENTUM, and PROPEL, which bring science to life on behalf of clients and their medical innovations. Founded in 2001 by Jay Greenzweig, RPh, FORCE Communications provides pharmaceutical, biotech, and medical device clients with customized medical communication and

Petauri™ Acquires FORCE Communications Read More »

Spectrum Science Acquires Continuum Clinical, Amplifying Patient Recruitment Capabilities

Spectrum Science, an independent, integrated healthcare and scientific marketing, communications, media and strategic services firm focused on the pharmaceutical, biotech and broader life science industries, announces the acquisition of Continuum Clinical, a global clinical trial recruitment and engagement solutions provider with a 30-year track record of success elevating interest, increasing access and enhancing experiences in

Spectrum Science Acquires Continuum Clinical, Amplifying Patient Recruitment Capabilities Read More »

Linden Capital Partners and Ontario Teachers’ Pension Plan Launch Initiative Focused on Clinical Research Advancement

Linden Capital Partners (Linden) and Ontario Teachers’ Pension Plan (Ontario Teachers’) are pleased to announce they are partnering on a transformative platform, led by Dr. John Potthoff, with the goal of revolutionizing the clinical research ecosystem. This strategic initiative is centered around investing in exceptional companies and deploying cutting-edge technology to foster seamless connections and

Linden Capital Partners and Ontario Teachers’ Pension Plan Launch Initiative Focused on Clinical Research Advancement Read More »

Scroll to Top